Bioinorganic Chemistry

with Medicinal Chemistry, Synthetic Chemistry, Analytical Chemistry, Bioanalytics and Cell Biology

The main emphasis at the Institute of Inorganic Chemistry is put on the subject of Bioinorganic Chemistry, Medicinal Chemistry, Synthetic Chemistry, Analytical Chemistry, Bioanalytics and Cell Biology, mainly focused on the development of novel tumor therapeutics.

The group has successfully contributed to this field for several years. Currently there are two new therapeutics developed in the group under clinical research.

 » Research Focus

» Publications

Together with:

• ao. Univ.-Prof. Dr. Mathea Galanski: Pt Chemistry, NMR Spectroscopy

• Dr. Tim Grüne: X-Ray Core Facility

• Dr. Michael Jakupec: Cell Culture Facility

• Dipl.-Ing. Dr. Wolfgang Kandioller Organometallic Chemistry

• Assoc. Prof. Dr. Christian Kowol: Prodrug Development, Drug Delivery Systems, Drug Targeting

• Michael Malarek, PhD: Organometallic Chemistry

• Ass.-Prof. Dr. Samuel Matthias Meier-Menches, Privatdoz: Translational Precision Analytics in Individualized Medicine (in cooperation with Institute of Analytical Chemistry

• Assoc. Prof. Dr. Michael Reithofer: Biomaterials, Nanochemistry

• Ass.-Prof. Dr. Peter Unfried: Rare Earth & Titanium Group Chemistry

• ao. Univ.-Prof. Dr. Vladimir Arion: Coordination Chemistry, Bioinorganic Chemistry, Organometallic Chemistry: Ruthenium and osmium arene complexes with biologically active ligands